Get Adobe Flash player

327 E. Ridgeville Blvd, #122
Mount Airy, MD 21771-3900

240.744.0000

866.935.STAT (7828)

866.276.STAT (7828)

info@empiristat.com

www.empiristat.com

Privacy Data Shield Policy

Contract Research and Clinical Trial Management Organization - Services

EmpiriStat Understands Your Program Objectives and Contributes at Every Stage

EmpiriStat's strength is our knowledge of every phase in your project, and the ability to understand and contribute to your program's objectives. We collaborate with you at every stage—from proposal development and grant writing to protocol development and statistical analysis planning...through programming and interpretation...to final validation and reporting.

Equally important are the practices and methodologies we apply throughout the entire timeline: rigorous quality control, thorough documentation, transparency, and regulatory compliance. EmpiriStat effectively becomes a part of your team—as well as your thought process. We proactively suggest improvements, offer guidance, and provide accurate, timely, and effective service.

 

Therapeutic Areas

EmpiriStat has a unique depth of experience across a broad range of therapeutic areas, and we have developed successful relationships with investigators on several continents.

Below are a few of our therapeutic areas...

  • Infectious Diseases
  • Vaccines
  • Traumatic Brain Injury
  • Transplants and Immunology
  • Anti-Infectives
  • Reproductive Health
  • Medical Devices
  • Dermatology
  • Blood Products
  • Wound Care
  • Oncology
  • Diabetes
  • Cardiovascular Disease

Services

Comments
from EmpiriStat Partners

"You have a great programming team that is highly efficient and communicates with ease. They do not sweat when the heat is on. They were able to run with little direction and produce high quality outputs; a nice group of 'thinkers', not just 'doers'. I am looking forward to reviewing the datasets next week or this weekend. Our sponsor will be excited/pleased to have the tight timeline delivered ahead of schedule. Great work!

Raven Quinn, MS
Biostatistician
Sarah Cannon Research Institute

"EmpiriStat's sense of urgency and their work is top-notch. They always deliver—and in this economy, that is what is most important."

Roger House, President
Axiom Corporation

"EmpiriStat runs a client-focused business with customer satisfaction and quality of services as their top priorities. They have a totally positive attitude—and are efficient, effective, responsive, and flexible."

Dr. Judi Chamberlin
U.S. Military HIV Research Program
Kisumu, Kenya

"EmpiriStat brought a genuine excitement about the science of our research and were very easy to reach. They asked insightful questions and were very prompt in their analysis and responses. It was a great pleasure to work with such professionals."

Theodore Henderson, MD, PhD
The Synaptic Space

"I'd heard Empiristat would be a good company to handle our statistical analysis. They were very patient while we waited for regulatory clearance, then incredibly fast and efficient when clearance finally came. Their data cleaning was nothing short of amazing, and when I asked them on short notice to write some abstracts for conferences, I was blown away by how quickly this was done—and they were extremely well-written. I can't say anything bad about Empiristat."

Mark Breda
Makerere University School of Medicine
Kampala, Uganda

"One of the great characteristics EmpiriStat brought to our projects was their genuine investment in ensuring the integrity of our data. Their respect for both our data and our study goals was a primary factor in our success."

Dr. Bob O'Brien
The CDM Group, Inc.

"We asked EmpiriStat to jump into a very specific role on a team already moving at high speed toward an NDA. She did this quickly, ably and cheerfully, and her work was integral to the submission. Her attention to detail and process were particularly appreciated, and her collaborative manner perfectly set the stage for a productive alliance."

Robert S. Fishman, MD, FCCP
VP, Clinical Development
Alexza Pharmaceuticals, Inc.